Clinical trial · Interventional
Disseminated Endometrial Cancer Cells During Sonohysterography
The Incidence of Disseminated Endometrial Cancer Cells During Sonohysterography and Their Functional Viability: a Prospective Study
NCT00205023CI-TRIAL-00041740completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of study is to: 1) determine critical volume necessary to overcome tubal pressure and result in fluid dissemination and 2) evaluate functional viability of any disseminated tumor cells collected during SHG
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sonohysterography | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- A
- interventionNames
- Procedure: Sonohysterography
Primary outcomes (1)
- measure
- determine the critical volume necessary to overcome tubal pressure and result in fluid dissemination during SHG
- timeFrame
- during surgery
Secondary outcomes (1)
- measure
- evaluate the functional viability of any disseminated tumor cells collected during SHG
- timeFrame
- during surgery
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Stage I endometrial Cancer Disease * State IIA endometrial Cancer Disease Exclusion Criteria: * Prior tubal ligation * Prior bilateral salpingectomy
References
Publications (0)
Data not yet available
No reference posted for this study.